GRP
IBB icon

Global Retirement Partners’s iShares Biotechnology ETF IBB Stock Holding History

Global Retirement Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.65M Buy
15,682
+298
+2% +$48.4K 0.05% 357
2025
Q3 		$2.22M Sell
15,384
-489
-3% -$66.7K 0.05% 329
2025
Q2 		$2.01M Buy
+15,873
New +$1.95M 0.05% 336
2024
Q4 		$4.65M Buy
35,172
+19,049
+118% +$2.68M 0.13% 153
2024
Q3 		$2.35M Sell
16,123
-191
-1% -$27.6K 0.07% 262
2024
Q2 		$2.24M Buy
16,314
+3,768
+30% +$503K 0.07% 257
2024
Q1 		$1.72M Buy
12,546
+10,674
+570% +$1.46M 0.06% 254
2023
Q4 		$254K Buy
1,872
+831
+80% +$101K 0.01% 665
2023
Q3 		$125K Sell
1,041
-533
-34% -$67.8K 0.01% 845
2023
Q2 		$200K Buy
1,574
+205
+15% +$26.6K 0.01% 699
2023
Q1 		$179K Sell
1,369
-462
-25% -$60.5K 0.01% 711
2022
Q4 		$240K Buy
1,831
+293
+19% +$37.9K 0.02% 551
2022
Q3 		$198K Buy
1,538
+433
+39% +$53.8K 0.02% 563
2022
Q2 		$130K Sell
1,105
-100
-8% -$11.9K 0.01% 665
2022
Q1 		$138K Buy
1,205
+301
+33% +$39.2K 0.01% 652
2021
Q4 		$138K Sell
904
-279
-24% -$43.2K 0.11% 59
2021
Q3 		$191K Sell
1,183
-33
-3% -$5.55K 0.02% 481
2021
Q2 		$199K Buy
1,216
+9
+0.7% +$1.39K 0.02% 455
2021
Q1 		$182K Sell
1,207
-373
-24% -$59.2K 0.02% 429
2020
Q4 		$239K Sell
1,580
-1,570
-50% -$224K 0.03% 367
2020
Q3 		$427K Buy
3,150
+33
+1% +$4.48K 0.06% 245
2020
Q2 		$426K Buy
3,117
+1,860
+148% +$237K 0.07% 245
2020
Q1 		$135K Sell
1,257
-71
-5% -$8.17K 0.03% 387
2019
Q4 		$160K Sell
1,328
-457
-26% -$51K 0.02% 408
2019
Q3 		$178K Sell
1,785
-1,178
-40% -$123K 0.03% 381
2019
Q2 		$323K Sell
2,963
-917
-24% -$97.5K 0.06% 252
2019
Q1 		$434K Buy
3,880
+99
+3% +$10.9K 0.11% 174
2018
Q4 		$365K Sell
3,781
-239
-6% -$25.4K 0.09% 206
2018
Q3 		$490K Sell
4,020
-111
-3% -$13.1K 0.11% 171
2018
Q2 		$454K Sell
4,131
-52
-1% -$5.56K 0.11% 175
2018
Q1 		$447K Sell
4,183
-94
-2% -$10.4K 0.12% 175
2017
Q4 		$460K Buy
4,277
+161
+4% +$17.2K 0.13% 156
2017
Q3 		$458K Buy
4,116
+561
+16% +$60K 0.19% 117
2017
Q2 		$368K Buy
3,555
+675
+23% +$66.5K 0.17% 120
2017
Q1 		$282K Sell
2,880
-3
-0.1% -$287 0.16% 126
2016
Q4 		$255K Buy
+2,883
New +$262K 0.17% 118

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Global Retirement Partners's IBB Position: Q4 2025 in Review

Global Retirement Partners increased its iShares Biotechnology ETF (IBB) stake by 1.9% in Q4 2025, buying an estimated $48.4K and bringing the position to 15,682 shares worth $2.65M. The position accounts for 0.05% of the portfolio, ranked #357.

Global Retirement Partners first reported a position in IBB in Q4 2016 and has held it in 36 quarters since. The position peaked at $4.65M in Q4 2024. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Global Retirement Partners held 15,682 shares of iShares Biotechnology ETF worth $2.65M as of Q4 2025.
  • Global Retirement Partners bought 298 iShares Biotechnology ETF shares in Q4 2025, an estimated $48.4K.
  • iShares Biotechnology ETF made up 0.05% of Global Retirement Partners's portfolio in Q4 2025, its #357 holding.
  • Global Retirement Partners first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 36 quarters since.
  • Global Retirement Partners's iShares Biotechnology ETF position peaked at $4.65M in Q4 2024.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.